Virtual Tumor Board: EGFR-mutant NSCLC

In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by Dr. Sara Pilotto and Dr. Jonathan Riess for a virtual tumor board discussion on the management of metastatic EGFR exon 19 NSCLC . Using a complex case featuring discordant biomarker results and brain metastases, the panel explores first-line treatment strategies including osimertinib monotherapy, FLAURA2 (osimertinib plus chemotherapy), and MARIPOSA (amivantamab plus lazertinib), as well as sequencing at progression, re-biopsy, CNS considerations, and the evolving role of local consolidation and clinical trials.

You can listen to Virtual Tumor Board: EGFR-mutant NSCLC online on Radio and Podcast. Open the player on this page to stream the available audio.

Virtual Tumor Board: EGFR-mutant NSCLC is an episode from Lung Cancer Considered by Lung Cancer Considered.

This episode is 00:47:44 long.

This episode was published on Mar 3, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Lung Cancer Considered when more episodes are available from the podcast feed.